Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.165 USD | -0.69% | +1.65% | -35.29% |
May. 13 | Truist Securities Trims Price Target on Coherus BioSciences to $7 From $8, Maintains Buy Rating | MT |
May. 09 | Transcript : Coherus BioSciences, Inc., Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-35.29% | 250M | |
+7.72% | 113B | |
+10.36% | 106B | |
+0.41% | 22.27B | |
-11.94% | 22.22B | |
-5.99% | 19.43B | |
-37.36% | 17.87B | |
-5.30% | 17.24B | |
+6.72% | 14.29B | |
+36.27% | 12.52B |
- Stock Market
- Equities
- CHRS Stock
- News Coherus BioSciences, Inc.
- Insider Sell: Coherus Biosciences